Printer Friendly

AMERICAN HOME PRODUCTS AND KENSEY NASH INITIATE CLINICAL TRIALS FOR HEMOSTATIC PUNCTURE CLOSURE DEVICE

AMERICAN HOME PRODUCTS AND KENSEY NASH INITIATE CLINICAL TRIALS FOR
 HEMOSTATIC PUNCTURE CLOSURE DEVICE
 NEW YORK, Nov. 14 /PRNewswire/ -- Quinton Instrument Company of Seattle, a division of American Home Products Corporation (NYSE: AHP), and Kensey Nash Corporation of Exton, Pa., announced today that clinical trials have begun in Europe for an innovative Hemostatic Puncture Closure Device (HPCD).
 This new device represents a major advance for the termination of cardiac catheterization procedures. The HPCD can be expected to significantly reduce the cost of procedures involving arterial punctures by reducing complications, staff time and length of patient stay. It may also improve the medical efficacy of these procedures by allowing more liberal use of anti-coagulants and larger bore catheters.
 The HPCD consists of a resorbable intra-arterial anchor and hemostatic collagen plug, connected by a resorbable suture. Immediately upon deployment, through the catheter sheath, the HPCD seals the puncture and stops the bleeding. Normally, pressure on the site is not required. In about 60 days, all components if the HPCD have been completely resorbed.
 Currently, diagnostic and interventional cardiac catheterization procedures commonly involve puncture of the femoral artery in the groin. To prevent bleeding from this puncture, after the procedure, usually requires a physician or nurse to hold pressure, manually or with a clamp, for 10 to 60 minutes, to ensure that a blood clot forms and is sufficiently stable to prevent rebleeding. Among the disadvantages of this process are the time of professional staff consumed, the high rate of complications, the necessity to reduce anti-coagulant dosages, and the discomfort to the patient.
 The Kensey Nash Corporation owns several U.S. and foreign patents protecting its HPCD technology and has granted American Home Products Corporation an exclusive, worldwide license to manufacture and market its HPCD technology.
 During the past decade, Kensey Nash Corporation has been actively researching and developing innovative medical devices and pharmaceutical products.
 American Home Products is a worldwide manufacturer and marketer of prescription drugs, medical supplies, diagnostics, over-the-counter medicines, and food products.
 -0- 11/14/91
 /CONTACT: John L. Skule, 212-878-5015, or John R. Considine (investors), 212-878-6429, both of American Home Products; or June Sheets of Kensey Nash, 215-524-0188/
 (AHP) CO: American Home Products; Kensey Nash Corp.; Quinton Instrument Co. ST: Pennsylvania, Washington IN: MTC SU: CK-SH -- NY024 -- 4337 11/14/91 10:28 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 14, 1991
Words:385
Previous Article:ENDEVCO REPORTS HIGHER REVENUES AND NET INCOME FOR THIRD QUARTER 1991
Next Article:IRT PROPERTY COMPANY REPORTS THIRD QUARTER 1991 RESULTS
Topics:


Related Articles
KENSEY NASH ANNOUNCES RE-LAUNCH OF ANGIO-SEAL IN EUROPE
KENSEY NASH INITIATES EARLY AMBULATION CLINICAL TRIAL FOR ANGIO-SEAL DEVICE
Kensey Nash Receives FDA Approval for Angio-Seal
Sherwood-Davis & Geck Announces FDA Approval of the Angio-Seal(TM) Device
Kensey Nash Announces Voluntary Recall of 8F Angio-Seal Product by Marketing Partner
Kensey Nash Announces Third Quarter Results; Kensey Nash Provides Clinical Program Update
Kensey Nash Announces FDA Approval of Expanded Indications for Angio-Seal
Sherwood-Davis & Geck Announces New Approval For Early Ambulation For Angio-Seal(TM) Device
Kensey Nash Acquires Patents Related to Puncture Closure Technology; Royalty Rates Paid to Kensey Nash Will Increase
Kensey Nash Announces New Supply Agreement for Angio-Seal(TM).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters